Hudelist et al., 2005 - Google Patents
Use of high-throughput arrays for profiling differentially expressed proteins in normal and malignant tissuesHudelist et al., 2005
- Document ID
- 5955044240264664192
- Author
- Hudelist G
- Singer C
- Kubista E
- Czerwenka K
- Publication year
- Publication venue
- Anti-cancer drugs
External Links
Snippet
DNA microarrays have provided researchers with a tool to detect differential expression of thousands of genes in a small sample and have clearly revolutionized the way gene expression analysis is now carried out. These microarrays are, however, confined to the …
- 102000004169 proteins and genes 0 title abstract description 102
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/543—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals
- G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/543—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MacBeath | Protein microarrays and proteomics | |
Woo et al. | High-throughput and high-efficiency sample preparation for single-cell proteomics using a nested nanowell chip | |
Tannapfel et al. | Identification of novel proteins associated with hepatocellular carcinomas using protein microarrays | |
Haab | Antibody arrays in cancer research | |
Sanchez-Carbayo | Antibody arrays: technical considerations and clinical applications in cancer | |
Chen et al. | Protein microarrays | |
Poetz et al. | Protein microarrays: catching the proteome | |
Claes et al. | MALDI-IHC-guided in-depth spatial proteomics: targeted and untargeted MSI combined | |
Liotta et al. | Molecular profiling of human cancer | |
Angenendt et al. | 3D protein microarrays: performing multiplex immunoassays on a single chip | |
Espina et al. | Protein microarray detection strategies: focus on direct detection technologies | |
Charboneau et al. | Utility of reverse phase protein arrays: applications to signalling pathways and human body arrays | |
Fredolini et al. | Immunocapture strategies in translational proteomics | |
Zhou et al. | Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives | |
Tanase et al. | Application of 3D hydrogel microarrays in molecular diagnostics: Advantages and limitations | |
Eisenstein | Growing pains | |
Pan et al. | Three-dimensionally functionalized reverse phase glycoprotein array for cancer biomarker discovery and validation | |
Taverna et al. | Histology-directed microwave assisted enzymatic protein digestion for MALDI MS analysis of mammalian tissue | |
Voshol et al. | Antibody‐based proteomics: analysis of signaling networks using reverse protein arrays | |
Wingren | Antibody-based proteomics | |
Sun | Use of microarrays as a high-throughput platform for label-free biosensing | |
Fulcher et al. | Parallel measurement of transcriptomes and proteomes from same single cells using nanodroplet splitting | |
Chaerkady et al. | Applications of proteomics to lab diagnosis | |
Hood et al. | Unravelling the proteome of formalin-fixed paraffin-embedded tissue | |
Hudelist et al. | Use of high-throughput arrays for profiling differentially expressed proteins in normal and malignant tissues |